Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar;26(3):617-619.
doi: 10.1016/j.drudis.2020.11.035. Epub 2021 Jan 11.

Modelling the World - can deliberately infecting healthy volunteers really tell us much about what happens outside the clinic during an epidemic or pandemic?

Affiliations
Editorial

Modelling the World - can deliberately infecting healthy volunteers really tell us much about what happens outside the clinic during an epidemic or pandemic?

Adrian Wildfire. Drug Discov Today. 2021 Mar.
No abstract available

PubMed Disclaimer

References

    1. World Health Organization . 2020. Accelerating a safe and effective COVID-19 vaccine.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-r... Accessed: October 15th, 2020.
    1. European Medicines Agency . 2020. A call to pool EU research resources into large-scale multi-centre, multi-arm clinical trials against COVID-19. EMA. EMA/136815/2020 Committee for Medicinal Products for Human Use. Retrieved from https://www.ema.europa.eu/en/documents/other/call-pool-eu-research-resou.... Accessed: October 15th, 2020.
    1. You L., Xin W., Harish N. Global seasonality of human seasonal coronaviruses: A clue for postpandemic circulating season of severe acute respiratory syndrome coronavirus 2? J. Infect. Dis. 2020;222(7):1090–1097. doi: 10.1093/infdis/jiaa436. - DOI - PMC - PubMed
    1. Thanh Le T., et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(May (5)):305–306. doi: 10.1038/d41573-020-00073-5. PMID: 32273591. - DOI - PubMed
    1. Rai S.N., et al. Statistical design of phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients. BMC Med. Res. Methodol. 2020;20:220. doi: 10.1186/s12874-020-01101-z. - DOI - PMC - PubMed

Publication types